Market Analysis 2019-2027 Antiviral Drug Resistance Market | Page 3

Global Antiviral Drug Resistance Market to 2027
www.theinsightpartners.com
Reaction), next generation sequencing and others. The viral infectious diseases is anticipated
to remain a major public health problem in the coming decades, which poses a threat to both
national and international health security. Endemic diseases including, human
immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) will
continue to challenge public health. For the early detection and rapid response, high level of
awareness is required across the region. Thus, the rapid growth and innovations coming from
the emerging nations are expected to increasing the growth opportunities and sales in the
global antiviral drug resistance market.
Product Insights
The global antiviral drug resistance market by product was led by kits and reagents segment.
In 2018, the segment of held the largest market share in the antiviral drug resistance market,
by product. The segment is also expected to witness growth at a significant rate during the
forecast period since they are an essential requirement for conducting various tests.
ANTIVIRAL DRUG RESISTANCE – MARKET SEGMENTATION
By Product
 Kits and Reagents
 Instruments
By Disease Indication
 Human Immunodeficiency Virus (HIV)
 Hepatitis
 Cytomegalovirus (CMV)
By Disease Technologies
 Immunodiagnostics
 Polymerase Chain Reaction (PCR)
 Next Generation Sequencing (NGS)
 Other Technologies
3